Drug Approval | April 26, 2022
USFDA approves first Covid-19 treatment for young children
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
Previously, the use of the drug was limited to patients requiring hospitalization
The authorization provides an additional treatment option against the Covid-19 virus in the form of a pill that can be taken orally
The approval is for Cytomegalovirus, a type of Herpes virus
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder
Subscribe To Our Newsletter & Stay Updated
